Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Capital Expenditures (2022 - 2025)

Historic Capital Expenditures for Gossamer Bio (GOSS) over the last 2 years, with Q2 2025 value amounting to $53000.0.

  • Gossamer Bio's Capital Expenditures changed N/A to $53000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $79000.0, marking a year-over-year change of. This contributed to the annual value of $410000.0 for FY2022, which is 7347.99% down from last year.
  • As of Q2 2025, Gossamer Bio's Capital Expenditures stood at $53000.0.
  • In the past 5 years, Gossamer Bio's Capital Expenditures ranged from a high of $157000.0 in Q1 2022 and a low of $26000.0 during Q1 2025